Edwards Lifesciences EW Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Edwards Lifesciences’s reported figures.
The official record: Edwards Lifesciences’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Edwards Lifesciences's free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Edwards Lifesciences's free cash flow?
- Edwards Lifesciences (EW) reported free cash flow of -$21.1M in Q1 2026.
- How has Edwards Lifesciences's free cash flow changed year-over-year?
- Edwards Lifesciences's free cash flow decreased by 109.4% year-over-year, from $224.4M to -$21.1M.
- What is the long-term trend for Edwards Lifesciences's free cash flow?
- Over 3 years (2021 to 2025), Edwards Lifesciences's free cash flow has grown at a -1.7% compound annual growth rate (CAGR), from $1.41B to $1.34B.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.